Nitrofurantoina macroc. 100mg cpcm rec 1000021860
About This Opportunity
Award by Chile Mercadopublico (Chile, healthcare): Nitrofurantoina macroc. 100mg cpcm rec. Awarded to ALEMBIC PHARMACEUTICALS SPA (CLP 663.4M, Apr 2026).
This is a supplies contract in the health and medical services and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender, originating from Chile and managed through mercadopublico.cl, seeks the supply of pharmaceutical products. Specifically, the procurement is for Nitrofurantoin Macrocrystalline 100mg coated tablets, identified by the reference number 1000021860. This represents a demand for essential medication within the Chilean healthcare system, likely for public hospitals, clinics, or health programs.
The contracting authority, operating within Chile, is looking to establish a reliable supply chain for this antibiotic. Nitrofurantoin is commonly prescribed for the treatment and prevention of urinary tract infections (UTIs). The specification for "macrocrystalline" indicates a particular formulation designed for improved absorption and potentially reduced gastrointestinal side effects compared to older forms. The "coated tablet" (cpcm) signifies a film-coated presentation, which can aid in swallowing and protect the active ingredient.
Typical requirements for such pharmaceutical tenders include adherence to stringent quality standards, such as Good Manufacturing Practices (GMP), and compliance with national regulatory requirements of Chile, overseen by the Instituto de Salud Pública (ISP). Bidders will likely need to demonstrate their ability to provide the specified dosage and quantity, with potential requirements for packaging, labeling in Spanish, and timely delivery to designated locations within Chile. Evidence of product registration and marketing authorization in Chile will be crucial. Furthermore, suppliers may be expected to provide product samples, certificates of analysis, and details of their quality control processes.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 14 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
How much was the contract awarded for?
ALEMBIC PHARMACEUTICALS SPA was awarded the contract for CLP 663,397,770. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to ALEMBIC PHARMACEUTICALS SPA. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.